Today’s reports cover such items as:
- Disparities in cancer mortality between blacks and whites in the USA
- Body mass, body fat distribution, and risk for prostate cancer
- Risk for cancer in male carriers of BRCA mutations
- A five-SNP genetic marker set and prostate cancer risk
- Final results of the atrasentan trial in non-metastatic, HRPC patients
- Is a rising plasma PDGF level an indicator for docetaxel failure? … READ MORE …
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: atrasentan, BMI, BRCA mutation, disparity, docetaxel, fat distribution, genetic marker, PGDF, SNP | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 